Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.167EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.267EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.165EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.554EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.243.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.2.5.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.450EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.130EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.444EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AW.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.268EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.344EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.103EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.485EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.119EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.276EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.111EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.515EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.287EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.431EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.170EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.506EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.6.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.438.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.27EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.30EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.513EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.338EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.284EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.9.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.498EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.184EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.187EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
D.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AE.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.110.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.342EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.500EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.511EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.428.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.506EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.482EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.335EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.36EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.499.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.38EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.116EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.547EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used